Cardiac cachexia in cats with congestive heart failure: Prevalence and clinical, laboratory, and survival findings

Nutritional Management of Cats and Dogs with Diabetes Mellitus

This article reviews the nutritional assessment and management of diabetic dogs and cats. It discusses how to determine appropriate nutritional goals for individual patients, including comorbid patients with diabetes. Considerations for macronutrient and micronutrient modifications will be reviewed.

Falciform fat:femur length ratio provides a novel method for objective postmortem estimation of total body fat in overweight and obese cats

Determination of the nutritional condition, including estimation of amounts of total body fat (tBF), at routine postmortem examination of cats is typically based on subjective visual assessment. Subjective assessment may result in uncertainties regarding degree of overweight, and objective methods that provide a numerical value reflecting the tBF could be valuable to accurately judge excess body fat. We investigated if the falciform fat pad weight (FFPW) was correlated to tBF and could be used to detect overweight and obesity in cats. The FFPW and the femur length (FL) were recorded at postmortem examination in 54 cats and the FFPW:FL ratio (FFR) calculated. Each cat was additionally assigned to a fat category (FC) according to subjective assessment. Computed tomography was used to determine tBF as the body fat percentage (%BF), the body fat volume (BFV), and BFV normalized to animal size (nBFV) in 39 cats. There was strong correlation between the FFPW and the BFV (r = 0.888) and between the FFR and the nBFV (r = 0.897). The correlation between the nBFV and %BF was very strong (r = 0.974). Using a lower FFR cutoff value of 3.5 for obesity and 1.6 for overweight, there was a discrepancy in FC between using the FFR and subjective assessment in 6 of 54 cats (11%). We conclude that the FFPW increases proportionally with tBF and that the FFR provides a method for objective tBF estimation. We suggest introducing the FFR to feline postmortem examination protocols as an objective estimate of tBF.

Prevalence, risk factors, and disease associations of overweight and obesity in cats that visited the Veterinary Medical Teaching Hospital at the University of California, Davis from January 2006 to December 2015

Overweight and obesity are commonly diagnosed in domestic cats, and undermine cats' quality of life directly or indirectly via various disease processes known to be associated with overweight and obesity. Epidemiological studies have reported varied overall prevalence among different feline populations, and commonly identified risk factors such as neutering. However, disease associations were not consistently reported. The status of feline overweight and obesity in a referral veterinary teaching hospital in the United States remains undefined as well. The present study used descriptive statistics and logistic regression models to analyze feline medical records obtained at the Veterinary Medical Teaching Hospital at the University of California, Davis from January 2006 to December 2015 and to characterize the prevalence of overweight and obesity, risk factors, and disease associations. In 9,062 feline records analyzed, the overall prevalence of overweight (17.2%; n = 1,560) and obesity (23.8%; n = 2,160) was 41.0%. Neutered, male, and crossbred cats that were in age groups between 3.0 and 14.9 years old and presented with disease processes in orthopedic, dentistry, and urinary categories were positively associated with overweight and obesity. Overweight and obesity are prevalent problems, which can benefit from continual veterinary education emphasizing its importance. Structured disease surveillance plans monitoring these associated factors also help guide further research and ideally can contribute to development of better prevention strategies for overweight and obesity.

Cardiac cachexia in cats with congestive heart failure: Prevalence and clinical, laboratory, and survival findings

BACKGROUND

Cardiac cachexia is common in people and dogs with congestive heart failure (CHF). However, the prevalence and effects of cardiac cachexia in cats are unknown.

OBJECTIVES

To determine the prevalence of cachexia and its associations with clinical laboratory and survival data in cats with CHF.

ANIMALS

One hundred twenty-five cats with CHF.

METHODS

Medical records of cats evaluated during a 40-month period were retrospectively reviewed to identify cats with cardiac cachexia using 7 different definitions. Clinical, laboratory, and survival data were compared between cats with and without cachexia.

RESULTS

Prevalence of cachexia ranged from 0 to 66.7% for the 7 definitions, with a prevalence of 41.6% using muscle condition score (MCS). Cats with cachexia (determined by MCS) were older (P < .001), more likely to have pleural effusion (P = .003), had significantly higher blood urea nitrogen (P < .001) and neutrophil concentrations (P = .01), and significantly lower body condition score (P < .001), body weights (P < .001), hematocrit (P = .007), and hemoglobin concentrations (P = .009). Survival time for cats with cachexia (determined by MCS) was significantly shorter than for cats without cachexia (P = .03). Cats that were underweight (P = .002) and cats with dilated cardiomyopathy (DCM) also had shorter survival times (P = .04).

CONCLUSIONS AND CLINICAL IMPORTANCE

The association between cachexia and reduced survival time emphasizes the importance of identifying and addressing this common problem in cats with CHF.